Market Quotes

7572 items in section

Celanese Hikes Liquid Crystal Polymer Prices Amid Supply Constraints

Persistent logistics bottlenecks and rising feedstock costs have forced Celanese to increase prices for its liquid crystal polymer products effective immediately. The chemical manufacturer cited a combination of sustained market demand and the continued instability of global raw material supply chains as the primary catalysts for this latest round of adjustments.

Niroshan Srirathan Named Permanent CFO at TOMI Environmental

Niroshan Srirathan has stepped into the permanent role of chief financial officer at TOMI Environmental Solutions, shedding the interim title he held since mid-May. The appointment marks the latest move in a swift internal promotion cycle for the executive at the environmental decontamination firm.

Air Canada and United Expand Transborder Flight Network

Over 4.3 million passengers have traveled between the United States and Canada via a joint venture that is now entering its next phase of growth. Air Canada and United Airlines have filed for regulatory approval to launch new routes and boost capacity across the border starting next summer.

Bond Yields Rebound as Markets Weigh Growth Against Inflation

83% of traders now expect the Federal Reserve to hold interest rates steady at the upcoming October meeting. This shift follows remarks from Chairman Kevin Warsh in Bangkok, as global government bond yields crept upward on Friday, retreating from the multiweek lows recorded just one day prior.

CN Healthy Food Tech to Resume Nasdaq Trading After Yearlong Halt

After a silence stretching more than a year, CN Healthy Food Tech Group is set to return to the Nasdaq exchange this Monday. The Zhuhai-based distributor of grain-based health products faced a sudden trading freeze following its merger with a special purpose acquisition company in late 2025.

Phillips 66 Increases Quarterly Dividend to $1.33 Per Share

Investors in Houston-based Phillips 66 are set to see a payout bump as the energy company raises its quarterly dividend by 4.7%. The new rate of $1.33 per share moves up from the previous $1.27, reflecting the firm's latest capital allocation decision announced by the board.

Omeros Faces European Setback for Narsoplimab

A 12% slide in Omeros shares followed the European Medicines Agency’s decision to uphold its rejection of narsoplimab, a specialized treatment for stem-cell transplant complications. The ruling marks a significant hurdle for the company’s expansion strategy, as regulators maintained their negative stance despite a formal request for re-examination.

NG Energy Surges as Colombian Gas Production Hits New Highs

Shares of NG Energy International climbed 11% to 1.08 Canadian dollars on Friday, fueled by a sharp increase in natural-gas production at the Maria Conchita block. The surge allows the Toronto-listed firm to capitalize on a constrained Colombian energy market by selling excess volumes at significant price premiums.

Quantum X Labs Stock Climbs Following Hardware Error Reduction Results

Shares of Quantum X Labs surged 8.5% to $4.21 by midday Friday after the firm successfully validated its LayerQake calibration methodology on three IBM quantum processors. The company’s stock has now nearly tripled this year as investors respond to technical benchmarks showing significant improvements in computational reliability.

Nvidia Launches AI-Optimized Laptops Starting at $2,599

With a starting price of $2,599, Nvidia has officially entered the personal computing market, rolling out a fleet of laptops equipped with its proprietary RTX Spark silicon. These machines prioritize on-device artificial intelligence, aiming to shift the standard for high-performance hardware toward autonomous AI agent integration.

City Therapeutics Jumps 25% Following Upsized $200 Million IPO

Investors pushed City Therapeutics shares to $22.53 in their first hours of public trading on Friday, a 25% gain from the company's initial offering price. The surge followed a late-Thursday announcement that the Cambridge-based biotechnology firm had successfully upsized its market debut, securing roughly $200 million in fresh capital.

U.S. Crude Rally Stalls as Global Supply Releases Offset Inventory Data

A six-day rally in U.S. crude prices hit a wall on Friday, as the November West Texas Intermediate contract slipped 45 cents to $97.52 per barrel. While the market retreats from recent peaks, the week remains defined by lingering supply anxieties and a significant injection of emergency reserves.

WaveDivision and Partners Acquire Internet Provider EarthLink

A consortium led by WaveDivision Capital, Stephens Capital Partners, and The Pritzker Organization has reached an agreement to acquire EarthLink. The deal, which includes participation from the internet provider's existing management team, signals a major shift in ownership for the U.S.-based service company as it prepares for further expansion.

Fox Factory CEO Departs Amid Slashing of Annual Forecast

Fox Factory shares plummeted 23% in premarket trading Friday after the company ousted CEO Mike Dennison and issued a sharp downward revision of its annual financial guidance. The abrupt leadership change coincides with significant operational headwinds across the firm's powered vehicle and aftermarket components divisions.

Hitachi Energy Targets Ontario for Major Transformer Supply Hub

With electricity demand surging across North America, Hitachi Energy is pouring C$479 million into a new transformer insulation plant in London, Ontario. The 21,000-square-meter facility marks Canada’s first domestic production site for pressboard and laminates, aimed at shortening supply chains for critical power grid infrastructure by 2028.

U.S. Corn Exports Surge Toward Top of Market Expectations

U.S. corn export sales reached 1.12 million metric tons for the week ending October 8, landing at the upper threshold of analyst forecasts. While the Department of Agriculture reported robust figures for corn, the broader agricultural export landscape showed signs of hesitation as market participants weighed overall demand.

U.S. Industrial Output Beats Expectations in September

U.S. industrial production climbed 0.7% in September, outpacing analyst projections of a 0.4% gain. The Federal Reserve's latest report highlights a robust month for the sector, bolstered by a significant surge in utility demand and an upwardly revised performance from August, which previously showed only a marginal 0.1% increase.

Faraday Future and FF EAI Robotics Debut Affordable Humanoid Line

Priced at $2,490, the new FF Nova humanoid robot aims to bring embodied artificial intelligence into classrooms and developer labs. The rollout, which includes a stripped-down $299 mini version, marks a strategic pivot for the companies as they finalize a $200 million merger to consolidate their robotics operations.

Alector Secures $75 Million in Premium Stock Offering

Alector shares climbed 6% to $2.03 in morning trading after the biotechnology firm priced a 36.6 million share offering at $2.05 apiece. This move represents a 7.3% premium over Thursday’s closing price, signaling strong market confidence despite the dilution of existing common stock.

A&W Canada Profits Rise on Smash Burger Success

A&W Food Services of Canada reported a 19.5 million Canadian dollar profit for the third quarter, a notable jump from the 17.6 million recorded a year ago. Driven by a successful smash-style burger campaign and the addition of nine new locations, the company is now pivoting toward a younger demographic.

Ascendis Pharma Secures EMA Nod for Achondroplasia Drug Yuviwel

The European Medicines Agency’s Committee for Medicinal Products for Human Use has issued a positive opinion recommending marketing authorization for Yuviwel, an Ascendis Pharma treatment designed to address achondroplasia in children. The decision marks a significant regulatory milestone for the therapy, which aims to mitigate the effects of the genetic disorder.

Regeneron Secures EU Support for Extended Libtayo Dosing Schedule

Patients undergoing treatment with the oncology drug Libtayo may soon face fewer clinical visits, as the European Medicines Agency’s Committee for Medicinal Products for Human Use endorsed a shift in administration frequency. The proposed change allows for a transition to a six-week dosing interval following an initial three-month induction period.

NiSource Secures 20-Year Power Agreement With Microsoft in Indiana

Microsoft has locked in a two-decade energy supply deal with NiSource to power a massive data center campus in Indiana. Starting in 2028, the tech giant will assume responsibility for its own infrastructure costs, a move designed to shield local ratepayers from the financial burden of rapid industrial expansion.

Tammi Gaskins to Lead Ironwood Pharmaceuticals in 2027

After seventeen years at the helm, Tom McCourt is stepping down as chief executive of Ironwood Pharmaceuticals. His successor, current Chief Commercial Officer Tammi Gaskins, will take command at the start of 2027, marking a significant transition for the Boston-based biotechnology firm as it navigates its next growth phase.

Emergent BioSolutions CFO Richard Lindahl to Retire

Richard Lindahl is stepping down as chief financial officer of Emergent BioSolutions, a company centered on manufacturing countermeasures for high-stakes health threats like anthrax and Ebola. The departure marks a shift in the firm’s executive ranks as it navigates a multi-year strategy to restructure its underlying business operations.

Lufax Names Jia Liu as New Finance Chief

Jia Liu steps into the role of chief financial officer at Lufax, filling a vacancy left by the resignation of Tongzhuan Xi. Her appointment marks a strategic move for the Chinese financial services provider, which focuses on delivering credit and wealth management solutions to small business owners across the country.

Silicon Motion Lifts Annual Dividend Following Storage Market Gains

Shareholders of Hong Kong-based Silicon Motion Technology are set for a boost, as the board of directors approved a 15% increase to the company’s annual dividend. The payout will climb to $2.30 per share from the previous $2.00, signaling a shift in the flash-storage controller maker's capital allocation strategy.

Navy Takes Delivery of New Super Hercules for Nuclear Command Mission

A new C-130J-30 Super Hercules arrived at the U.S. Navy’s hangar on Thursday, marking a pivotal transition for the military’s nuclear command-and-control infrastructure. Delivered at Lockheed Martin’s Marietta, Georgia facility, the airframe is slated for a specialized conversion into the E-130J Phoenix II, reviving a legacy of Hercules-based strategic communications.

EMA Rejects Omeros’ Narsoplimab Appeal

The European Medicines Agency has affirmed its original refusal to authorize narsoplimab, a drug intended to treat a life-threatening complication arising from stem cell transplants. This second negative opinion from the Committee for Medicinal Products for Human Use effectively stalls the company's efforts to bring the therapy to the European market.

Ionis Pharmaceuticals Wins EU Regulatory Support for Tryngolza

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended expanding the approval of Tryngolza, a treatment for adults struggling with severe hypertriglyceridemia. This endorsement marks a significant regulatory milestone for the Carlsbad-based company as it seeks to broaden access to the therapy across European markets.